 Home > Active Ingredient News > Immunology News > Ann Rheum Dis: How safe is the SARS-CoV-2 vaccine in patients with rheumatic and musculoskeletal diseases?

Ann Rheum Dis: How safe is the SARS-CoV-2 vaccine in patients with rheumatic and musculoskeletal diseases?

 Last Update: 2022-01-21
 Source: Internet
 Author: User

Tags

mcv vaccine name

vaccine needle

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Recently, a research article was published in Annals of the Rheumatic Diseases, a top journal in the field of rheumatology, which aims to clarify the role of SARS-CoV-2 vaccine in patients with inflammatory/ autoimmune rheumatic and musculoskeletal diseases (I-RMD).

immunity

We identified patients with I-RMD and non-inflammatory RMDs (NI-RMDs) who were vaccinated against SARS-CoV-2 between February 5, 2021, and July 27, 2021 from the Physician Report Registry, and collected Data on demographics , vaccinations, RMD diagnosis , disease activity, immunomodulatory/immunosuppressive therapy, episodes, adverse events (AEs), and SARS-CoV-2 breakthrough infection were presented

Statistical diagnosis of infection

The study included 5121 participants from 30 countries, 90% of whom had I-RMD (n=4604, 68% women, mean age 60.

Blood vessel

Most patients received the Pfizer/BioNTech vaccine (70%), 17% received the AstraZeneca/Oxford vaccine, and 8% received the Moderna vaccine

Thus, the safety of SARS-CoV-2 vaccine in I-RMD patients is reassuring and comparable to NI-RMD patients

The safety profile of SARS-CoV-2 vaccine in I-RMD patients is reassuring and comparable to NI-RMD patients

Original source:

Pedro M Machado, et al.

Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

High Purity 99% BPN14770 Zatolmilast 1606974-33-7 In Stock Fast Ship to USA

CAS No.: 1606974-33-7

Pharm Grade

$1-1.1/UNIT FOB

High quality Thymosin α1 Pure CAS 62304-98-7 Thymosin Alpha 1 Thymalfasin

CAS No.: 62304-98-7

Pharmacy Grade

$12-15/UNIT FOB

Top quantity Imiquimod CAS NO 99011-02-6 White crystalline powder 99% API

CAS No.: 99011-02-6

Pharmacy Grade

$1800-1850/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.